Carbiotix AB (publ) (NGM:CRBX)

Sweden flag Sweden · Delayed Price · Currency is SEK
11.00
+0.20 (1.85%)
At close: Jul 23, 2025
1.85%
Market Cap51.99M
Revenue (ttm)2.27M
Net Income (ttm)-16.07M
Shares Out4.64M
EPS (ttm)-3.85
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume3,218
Average Volume2,750
Open10.15
Previous Close10.80
Day's Range10.15 - 11.00
52-Week Range4.40 - 19.00
Beta0.74
RSI60.55
Earnings DateAug 5, 2025

About Carbiotix AB

Carbiotix AB (publ), a biotechnology company develops health testing and microbiome modulators to address a range of chronic and metabolic diseases. Its portfolio includes prebiotic ingredients and diagnostic testing services. The company develops CarbiAXOS, a second-generation prebiotic soluble fiber based on virgin and upcycled natural substrates containing arabinoxylo-oligosaccharides that is customized to meet customer needs to the production of short chain fatty acids or any other effect; and LinkGut, a health test. Carbiotix AB (publ) was... [Read more]

Industry Biological Products, Except Diagnostic Substances
Founded 2014
Employees 8
Stock Exchange Nordic Growth Market
Ticker Symbol CRBX
Full Company Profile

Financial Performance

In 2024, Carbiotix AB's revenue was 2.86 million, a decrease of -33.38% compared to the previous year's 4.29 million. Losses were -16.13 million, 19.7% more than in 2023.

Financial Statements

News

There is no news available yet.